Cholesterol-lowering statin drugs appear to be associated with reduced risk of recurrent cardiovascular events in men and women, but do not appear to be associated with reduced all-cause mortality or stroke in women, according to a report of a meta-analysis published June 25 in the Archives of Internal Medicine, a JAMA Network publication.
135777
Statins appear associated with reduced risk of recurrent cardiovascular events in men, women
58443
Why women live longer than men:
86614
Diabetes drug may lead to heart problems
33604
High levels of apolipoproteins are a predictor of heart attack risk
119923
Avandia increases risk of heart problems
81703
Women take different risks than men
120207
Common painkillers may lower a man's risk of prostate cancer
126175
Kidney disease increases the risk of stroke in patients
68782
Use of drug-eluting stents varies widely;
61385
Men with asthma or eczema at lower risk of developing cancer
151059
Moderate physical activity may reduce postmenopausal breast cancer risk
92086
Aspirin won't prevent heart attack
174826
Hypercholesterolemia partnering 2007-2012
79794
Dietary supplements may not halt bone loss
156354
Women are more vulnerable to carbohydrates than men
85683
Nature Clinical Practice Cardiovascular Medicine publishes Clinical research
149378
Recent guidelines recommend cholesterol tests for children fail to weigh health benefits